Pathologic separation of idiopathic pulmonary fibrosis from fibrotic hypersensitivity pneumonitis.
Aged
Alveolitis, Extrinsic Allergic
/ diagnostic imaging
Biopsy
Chronic Disease
Cross-Sectional Studies
Diagnosis, Differential
Female
Humans
Idiopathic Pulmonary Fibrosis
/ diagnostic imaging
Lung
/ diagnostic imaging
Male
Middle Aged
Predictive Value of Tests
Retrospective Studies
Risk Factors
Tomography, X-Ray Computed
Journal
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
ISSN: 1530-0285
Titre abrégé: Mod Pathol
Pays: United States
ID NLM: 8806605
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
01
07
2019
accepted:
24
09
2019
revised:
22
09
2019
pubmed:
30
10
2019
medline:
26
1
2021
entrez:
30
10
2019
Statut:
ppublish
Résumé
Accurate separation of idiopathic pulmonary fibrosis from fibrotic (chronic) hypersensitivity pneumonitis is crucial to patient management, but is frequently a difficult problem. Our objective was to identify pathologic variables that help make this separation. Clinical, radiological, and pathologic data were re-reviewed for 23 patients with a fibrotic interstitial lung disease and biopsy suggesting idiopathic pulmonary fibrosis or fibrotic hypersensitivity pneumonitis. Clinical features, high-resolution computed tomography, and surgical lung biopsies were each examined independently using a prespecified approach. This was followed by a multidisciplinary discussion in which the likelihood of an idiopathic pulmonary fibrosis diagnosis was assigned by the clinician alone based only on clinical data, by the clinician and radiologist based on integrated clinical and radiologic data, and by the clinician, radiologist, and pathologist based on all three domains. A higher multidisciplinary discussion-based confidence of idiopathic pulmonary fibrosis was associated with older age at diagnosis, male sex, higher forced vital capacity, and absence of ground glass changes. Pathologic variables associated with a higher multidisciplinary discussion-based confidence of idiopathic pulmonary fibrosis included increased number of fibroblast foci/cm
Identifiants
pubmed: 31659276
doi: 10.1038/s41379-019-0389-3
pii: S0893-3952(22)00887-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
616-625Références
Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733–48.
doi: 10.1164/rccm.201308-1483ST
Guler SA, Ellison K, Algamdi M, Collard HR, Ryerson CJ. Heterogeneity in unclassifiable interstitial lung disease. A systematic review and meta-analysis. Ann Am Thorac Soc. 2018;15:854–63.
doi: 10.1513/AnnalsATS.201801-067OC
Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198:e44–68.
doi: 10.1164/rccm.201807-1255ST
Morell F, Villar A, Montero MA, Munoz X, Colby TV, Pipvath S, et al. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. Lancet Respir Med. 2013;1:685–94.
doi: 10.1016/S2213-2600(13)70191-7
Walsh SL, Calandriello L, Sverzellati N, Wells AU, Hansell DM, Consort UIPO. Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT. Thorax. 2016;71:45–51.
doi: 10.1136/thoraxjnl-2015-207252
Walsh SL, Wells AU, Desai SR, Poletti V, Piciucchi S, Dubini A, et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med. 2016;4:557–65.
doi: 10.1016/S2213-2600(16)30033-9
Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med. 2018;6:138–53.
doi: 10.1016/S2213-2600(17)30433-2
Churg A, Bilawich A, Wright JL. Pathology of chronic hypersensitivity pneumonitis what is it? What are the diagnostic criteria? Why do we care? Arch Pathol Lab Med. 2018;142:109–19.
doi: 10.5858/arpa.2017-0173-RA
Takemura T, Akashi T, Kamiya H, Ikushima S, Ando T, Oritsu M, et al. Pathological differentiation of chronic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis/usual interstitial pneumonia. Histopathol. 2012;61:1026–35.
doi: 10.1111/j.1365-2559.2012.04322.x
Hashisako M, Tanaka T, Terasaki Y, Uekusa T, Achcar RD, Aswad BI, et al. Interobserver agreement of usual interstitial pneumonia diagnosis correlated with patient outcome. Arch Pathol Lab Med. 2016;140:1375–82.
doi: 10.5858/arpa.2016-0012-OA
Churg A, Wright JL, Ryerson CJ. Pathologic separation of chronic hypersensitivity pneumonitis from fibrotic connective tissue disease-associated interstitial lung disease. Am J Surg Pathol. 2017;41:1403–19.
doi: 10.1097/PAS.0000000000000885
Morisset J, Johannson KA, Jones KD, Wolters PJ, Collard HR, Walsh SLF, et al. Identification of diagnostic criteria for chronic hypersensitivity pneumonitis: an International Modified Delphi Survey. Am J Respir Crit Care Med. 2018;197:1036–44.
doi: 10.1164/rccm.201710-1986OC
Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015;46:976–87.
doi: 10.1183/13993003.00150-2015
Bolender RP, Hyde DM, Dehoff RT. Lung morphometry: a new generation of tools and experiments for organ, tissue, cell, and molecular biology. Am J Physiol. 1993;265:L521–48.
doi: 10.1152/ajpcell.1993.265.2.C521
Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, et al. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study. Eur Respir J. 2017;50:1700936.
doi: 10.1183/13993003.00936-2017
Ryerson CJ, Corte TJ, Lee JS, Richeldi L, Walsh SLF, Myers JL, et al. A standardized diagnostic ontology for fibrotic interstitial lung disease. An international working group perspective. Am J Respir Crit Care Med. 2017;196:1249–54.
doi: 10.1164/rccm.201702-0400PP
Silva CI, Muller NL, Lynch DA, Curran-Everett D, Brown KK, Lee KS, et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology. 2008;246:288–97.
doi: 10.1148/radiol.2453061881
Churg A, Sin DD, Everett D, Brown K, Cool C. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2009;33:1765–70.
doi: 10.1097/PAS.0b013e3181bb2538
Tanizawa K, Ley B, Vittinghoff E, Elicker BM, Henry TS, Wolters PJ, et al. Significance of bronchiolocentric fibrosis in patients with histopathological usual interstitial pneumonia. Histopathol. 2019;74:1088–97.
doi: 10.1111/his.13840
Flaherty KR, King TE Jr., Raghu G, Lynch JP 3rd, Colby TV, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med. 2004;170:904–10.
doi: 10.1164/rccm.200402-147OC